UniProt ID | CCND1_HUMAN | |
---|---|---|
UniProt AC | P24385 | |
Protein Name | G1/S-specific cyclin-D1 | |
Gene Name | CCND1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 295 | |
Subcellular Localization | Nucleus . Cytoplasm . Membrane . Cyclin D-CDK4 complexes accumulate at the nuclear membrane and are then translocated to the nucleus through interaction with KIP/CIP family members.. | |
Protein Description | Regulatory component of the cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity. Component of the ternary complex, cyclin D1/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex. Exhibits transcriptional corepressor activity with INSM1 on the NEUROD1 and INS promoters in a cell cycle-independent manner.. | |
Protein Sequence | MEHQLLCCEVETIRRAYPDANLLNDRVLRAMLKAEETCAPSVSYFKCVQKEVLPSMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRLQLLGATCMFVASKMKETIPLTAEKLCIYTDNSIRPEELLQMELLLVNKLKWNLAAMTPHDFIEHFLSKMPEAEENKQIIRKHAQTFVALCATDVKFISNPPSMVAAGSVVAAVQGLNLRSPNNFLSYYRLTRFLSRVIKCDPDCLRACQEQIEALLESSLRQAQQNMDPKAAEEEEEEEEEVDLACTPTDVRDVDI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
33 | Sumoylation | RVLRAMLKAEETCAP HHHHHHHHHHHHCCC | 40.44 | - | |
33 | Ubiquitination | RVLRAMLKAEETCAP HHHHHHHHHHHHCCC | 40.44 | - | |
37 | Phosphorylation | AMLKAEETCAPSVSY HHHHHHHHCCCCCCH | 12.89 | 30177828 | |
41 | Phosphorylation | AEETCAPSVSYFKCV HHHHCCCCCCHHHHH | 12.74 | 28355574 | |
43 | Phosphorylation | ETCAPSVSYFKCVQK HHCCCCCCHHHHHHH | 29.23 | 30108239 | |
44 | Phosphorylation | TCAPSVSYFKCVQKE HCCCCCCHHHHHHHH | 12.61 | 30177828 | |
46 | Methylation | APSVSYFKCVQKEVL CCCCCHHHHHHHHHH | 25.84 | - | |
46 | Ubiquitination | APSVSYFKCVQKEVL CCCCCHHHHHHHHHH | 25.84 | - | |
50 | Ubiquitination | SYFKCVQKEVLPSMR CHHHHHHHHHHHHHH | 29.41 | - | |
90 | Phosphorylation | NYLDRFLSLEPVKKS HHHHHHHCCCCCCHH | 28.16 | 22817900 | |
95 | Ubiquitination | FLSLEPVKKSRLQLL HHCCCCCCHHHHHHH | 56.60 | 21906983 | |
96 | Ubiquitination | LSLEPVKKSRLQLLG HCCCCCCHHHHHHHH | 40.83 | - | |
111 | Phosphorylation | ATCMFVASKMKETIP HHHHHHHHHCCCCCC | 28.16 | - | |
112 | Ubiquitination | TCMFVASKMKETIPL HHHHHHHHCCCCCCC | 44.23 | - | |
114 | Ubiquitination | MFVASKMKETIPLTA HHHHHHCCCCCCCCH | 56.28 | 21906983 | |
131 | Phosphorylation | LCIYTDNSIRPEELL HHHCCCCCCCHHHHH | 23.84 | - | |
149 | Ubiquitination | LLLVNKLKWNLAAMT HHHHHHHHHHHHHCC | 35.33 | - | |
167 | Ubiquitination | FIEHFLSKMPEAEEN HHHHHHHCCCHHHHH | 61.70 | 21906983 | |
175 | Ubiquitination | MPEAEENKQIIRKHA CCHHHHHHHHHHHHH | 46.27 | 21906983 | |
180 | Ubiquitination | ENKQIIRKHAQTFVA HHHHHHHHHHHHHHH | 32.65 | - | |
197 | Phosphorylation | ATDVKFISNPPSMVA HCCCHHHCCCHHHHH | 46.55 | 22817900 | |
219 | Phosphorylation | VQGLNLRSPNNFLSY HHCCCCCCCCCHHHH | 34.84 | 24719451 | |
226 | Phosphorylation | SPNNFLSYYRLTRFL CCCCHHHHHHHHHHH | 8.51 | 17053785 | |
234 | Phosphorylation | YRLTRFLSRVIKCDP HHHHHHHHHHHCCCH | 23.07 | 22817900 | |
238 | Ubiquitination | RFLSRVIKCDPDCLR HHHHHHHCCCHHHHH | 29.72 | 21906983 | |
257 | Phosphorylation | QIEALLESSLRQAQQ HHHHHHHHHHHHHHH | 34.34 | 28450419 | |
258 | Phosphorylation | IEALLESSLRQAQQN HHHHHHHHHHHHHHH | 20.42 | 28450419 | |
269 | Ubiquitination | AQQNMDPKAAEEEEE HHHHCCHHHHHHHHH | 56.83 | 1976777 | |
286 | Phosphorylation | EEVDLACTPTDVRDV HHCCCCCCCCCCCCC | 24.50 | 10766840 | |
288 | Phosphorylation | VDLACTPTDVRDVDI CCCCCCCCCCCCCCC | 29.04 | 10766840 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
90 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
90 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
90 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
197 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
197 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
197 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
234 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
234 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
234 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
286 | T | Phosphorylation | Kinase | DYRK1A | Q13627 | PSP |
286 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
286 | T | Phosphorylation | Kinase | CHUK | O15111 | GPS |
286 | T | Phosphorylation | Kinase | GSK-FAMILY | - | GPS |
286 | T | Phosphorylation | Kinase | IKK-FAMILY | - | GPS |
286 | T | Phosphorylation | Kinase | GSK-3_GROUP | - | PhosphoELM |
288 | T | Phosphorylation | Kinase | DYRK1B | Q9Y463 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXW8 | Q8N3Y1 | PMID:17205132 |
- | K | Ubiquitination | E3 ubiquitin ligase | UHRF2 | Q96PU4 | PMID:21952639 |
- | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:24658274 |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXO4 | Q9UKT5 | PMID:17081987 |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXO31 | Q5XUX0 | PMID:20664978 |
- | K | Ubiquitination | E3 ubiquitin ligase | HACE1 | Q8IYU2 | PMID:17694067 |
- | K | Ubiquitination | E3 ubiquitin ligase | SKP2 | Q13309 | PMID:11439327 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CCND1_HUMAN !! |
Kegg Disease | |
---|---|
H00006 | Hairy-cell leukemia |
H00010 | Multiple myeloma |
H00016 | Oral cancer |
H00017 | Esophageal cancer |
H00031 | Breast cancer |
H00047 | Gallbladder cancer |
H00055 | Laryngeal cancer |
H00559 | von Hippel-Lindau syndrome |
OMIM Disease | |
Note=A chromosomal aberration involving CCND1 may be a cause of B-lymphocytic malignancy, particularly mantle-cell lymphoma (MCL). Translocation t(11 | |
14)(q13 | |
q32) with immunoglobulin gene regions. Activation of CCND1 may be oncogenic by directly altering progression through the cell cycle. | |
254500 | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB01169 | Arsenic trioxide |
loading...
Phosphorylation | |
Reference | PubMed |
"F-box protein FBXO31 mediates cyclin D1 degradation to induce G1arrest after DNA damage."; Santra M.K., Wajapeyee N., Green M.R.; Nature 459:722-725(2009). Cited for: PHOSPHORYLATION AT THR-286, UBIQUITINATION, AND MUTAGENESIS OFTHR-286. | |
"Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling."; Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.; EMBO J. 25:5058-5070(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-226, AND MASSSPECTROMETRY. |